People
Shota Ozawa
Shota Ozawa was a Director at MP Healthcare Venture Management from June 2023 to June 2026 according to his own public professional profile. LiberoThera’s August 1, 2024 primary financing announcement independently names him as MPH Director when he joined that company’s board. His profile places him in Tanabe Pharma’s Transformation Division from July 2026, following earlier research and business-development positions at Mitsubishi Tanabe Pharma. His education includes medicine at Kyoto University, biophysics and biochemistry at the University of Tokyo and an MBA at UMass Lowell. AMED’s current registered-VC list still names him as an MPH contact; this registration is qualified against the subsequent employment chronology, rather than presented as proof of a current Director appointment. Source employment dates are month-only.
Roles
Former Director (June 2023–June 2026); AMED directory contact